Samuel C. Mok

19.5k total citations · 1 hit paper
243 papers, 14.2k citations indexed

About

Samuel C. Mok is a scholar working on Molecular Biology, Reproductive Medicine and Cancer Research. According to data from OpenAlex, Samuel C. Mok has authored 243 papers receiving a total of 14.2k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Molecular Biology, 91 papers in Reproductive Medicine and 72 papers in Cancer Research. Recurrent topics in Samuel C. Mok's work include Ovarian cancer diagnosis and treatment (89 papers), RNA modifications and cancer (25 papers) and Cancer-related molecular mechanisms research (24 papers). Samuel C. Mok is often cited by papers focused on Ovarian cancer diagnosis and treatment (89 papers), RNA modifications and cancer (25 papers) and Cancer-related molecular mechanisms research (24 papers). Samuel C. Mok collaborates with scholars based in United States, Hong Kong and China. Samuel C. Mok's co-authors include Ross S. Berkowitz, Kwong‐Kwok Wong, William R. Welch, Michael J. Birrer, Tsz-Lun Yeung, Michael G. Muto, Karen H. Lu, Cecilia S. Leung, Kay‐Pong Yip and Jinsong Liu and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Samuel C. Mok

240 papers receiving 13.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1

2016 622 citations Tsz-Lun Yeung, Suet‐Ying Kwan et al. Nature Communications profile →

Peers

Countries citing papers authored by Samuel C. Mok

Since Specialization

Citations

This map shows the geographic impact of Samuel C. Mok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel C. Mok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel C. Mok more than expected).

Fields of papers citing papers by Samuel C. Mok

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel C. Mok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel C. Mok. The network helps show where Samuel C. Mok may publish in the future.

Co-authorship network of co-authors of Samuel C. Mok

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel C. Mok. A scholar is included among the top collaborators of Samuel C. Mok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel C. Mok. Samuel C. Mok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Upregulation of ryanodine receptor-1 dependent calcium signaling contributes to the malignance of high-grade serous ovarian cancer (HGSOC) 2023 ·Biophysical Journal ·(unknown), (unknown), Li Zhang, Samuel C. Mok, James S.K. Sham	1
2	Spatial Transcriptomics Depict Ligand–Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer Survivors 2023 ·Cancer Research ·Sammy Ferri‐Borgogno, Ying Zhu, Jianting Sheng, Jared K. Burks, Javier A. Gomez, Kwong‐Kwok Wong, Stephen T.C. Wong, Samuel C. Mok	58
3	Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors 2023 ·Molecular Cancer Research ·(unknown), (unknown), (unknown), Namrata Khurana, Joseph Celestino, Hannah C. Beird, Curtis Gumbs, Latasha Little, (unknown), Bryan Fellman, (unknown), (unknown), Sammy Ferri‐Borgogno, Samuel C. Mok, Russell R. Broaddus, David M. Gershenson, P. Andrew Futreal, R. Tyler Hillman	7
4	ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment 2020 ·Nature Communications ·(unknown), Tsz-Lun Yeung, Abhinav Achreja, Hongyun Zhao, Kay‐Pong Yip, Suet‐Ying Kwan, Michaela Onstad, Jianting Sheng, Ying Zhu, Dodge L. Baluya, (unknown), Ángela Rynne‐Vidal, Rosemarie Schmandt, Matthew L. Anderson, Karen H. Lu, Stephen T.C. Wong, Deepak Nagrath, Samuel C. Mok	39
5	Anticancer Immunotherapy by MFAP5 Blockade Inhibits Fibrosis and Enhances Chemosensitivity in Ovarian and Pancreatic Cancer 2019 ·Clinical Cancer Research ·Tsz-Lun Yeung, Cecilia S. Leung, Kay‐Pong Yip, Jianting Sheng, Long Vien, Laura Bover, Michael J. Birrer, Stephen T.C. Wong, Samuel C. Mok	48
6	The Impact of Stroma Admixture on Molecular Subtypes and Prognostic Gene Signatures in Serous Ovarian Cancer 2019 ·Cancer Epidemiology Biomarkers & Prevention ·Matthew Schwede, Levi Waldron, Samuel C. Mok, Wei Wei, (unknown), Melissa A. Merritt, Constantine S. Mitsiades, Giovanni Parmigiani, David P. Harrington, John Quackenbush, Michael J. Birrer, Aedín C. Culhane	24
7	Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancers 2019 ·Nature Communications ·Hatice U. Osmanbeyoglu, Fumiko Shimizu, Ángela Rynne‐Vidal, Direna Alonso‐Curbelo, Hsuan-An Chen, Hannah Y. Wen, Tsz-Lun Yeung, Petar Jelinic, Pedram Razavi, Scott W. Lowe, Samuel C. Mok, Gabriela Chiosis, Douglas A. Levine, Christina S. Leslie	18
8	Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters 2017 ·Clinical Cancer Research ·(unknown), Qian Zhang, Zhongyuan Chen, Han Liang, Gary B. Chisholm, Ying Yuan, Samuel C. Mok, Russell R. Broaddus, Karen H. Lu, Melinda S. Yates	92
9	TGF-β Modulates Ovarian Cancer Invasion by Upregulating CAF-Derived Versican in the Tumor Microenvironment 2013 ·Cancer Research ·Tsz-Lun Yeung, Cecilia S. Leung, Kwong‐Kwok Wong, Goli Samimi, Melissa S. Thompson, Jinsong Liu, Tarrik M. Zaid, Sue Ghosh, Michael J. Birrer, Samuel C. Mok	313
10	Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer 2013 ·Clinical Cancer Research ·Tarrik M. Zaid, Tsz-Lun Yeung, Melissa S. Thompson, Cecilia S. Leung, Tom Harding, (unknown), (unknown), Suet‐Ying Kwan, (unknown), Gabriel Lopez‐Berestein, Anil K. Sood, Kwong‐Kwok Wong, Michael J. Birrer, Samuel C. Mok	74
11	Microscopic and Early-Stage Ovarian Cancers in BRCA1/2 Mutation Carriers: Building a Model for Early BRCA-Associated Tumorigenesis 2011 ·Cancer Prevention Research ·Melinda S. Yates, Larissa A. Meyer, Michael T. Deavers, Molly S. Daniels, (unknown), Samuel C. Mok, David M. Gershenson, Karen H. Lu	43
12	C Terminus of Clostridium perfringens Enterotoxin Downregulates CLDN4 and Sensitizes Ovarian Cancer Cells to Taxol and Carboplatin 2010 ·Clinical Cancer Research ·Zhijian Gao, Xiaoyin Xu, Bruce A. McClane, Qing Zeng, Babak Litkouhi, William R. Welch, Ross S. Berkowitz, Samuel C. Mok, Elizabeth Garner	43
13	S1P differentially regulates migration of human ovarian cancer and human ovarian surface epithelial cells 2008 ·Molecular Cancer Therapeutics ·Dongmei Wang, Zhenwen Zhao, Andrea Caperell–Grant, Gong Yang, Samuel C. Mok, Jinsong Liu, Robert M. Bigsby, Yan Xu	53
14	Expression Profiling of Mucinous Tumors of the Ovary Identifies Genes of Clinicopathologic Importance 2006 ·Clinical Cancer Research ·Fred Wamunyokoli, Tomás Bonome, (unknown), Colleen M. Feltmate, William R. Welch, Mike Radonovich, Cindy A. Pise-Masison, John Brady, Ke Hao, Ross S. Berkowitz, Samuel C. Mok, Michael J. Birrer	50
15	Whole-Genome Allelotyping Identified Distinct Loss-of-Heterozygosity Patterns in Mucinous Ovarian and Appendiceal Carcinomas 2005 ·Clinical Cancer Research ·Colleen M. Feltmate, Kenneth R. Lee, Michael E. Johnson, John O. Schorge, Kwong‐Kwok Wong, Ke Hao, William R. Welch, Debra A. Bell, Ross S. Berkowitz, Samuel C. Mok	17
16	Human Epididymis Protein 4 (HE4) Is a Secreted Glycoprotein that Is Overexpressed by Serous and Endometrioid Ovarian Carcinomas 2005 ·Cancer Research ·Ronny Drapkin, Hans Henning von Horsten, Yafang Lin, Samuel C. Mok, Christopher P. Crum, William R. Welch, Jonathan L. Hecht	457
17	Expression Profiling of Serous Low Malignant Potential, Low-Grade, and High-Grade Tumors of the Ovary 2005 ·Cancer Research ·Tomás Bonome, (unknown), Dong-Choon Park, Mike Radonovich, Cindy A. Pise-Masison, John Brady, Ginger J. Gardner, Ke Hao, Wing H. Wong, J. Carl Barrett, Karen H. Lu, Anil K. Sood, David M. Gershenson, Samuel C. Mok, Michael J. Birrer	238
18	Overexpression of αvβ6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade 2002 ·Carcinogenesis ·Nuzhat Ahmed, (unknown), (unknown), Padma Murthi, Michael Quinn, Gregory E. Rice, Michael Agrez, Samuel C. Mok, Mark S. Baker	111
19	Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum. 1995 ·PubMed ·Michael G. Muto, (unknown), Samuel C. Mok, Christina A. Bandera, (unknown), S W Tsao, (unknown), H. M. Goodman, Robert C. Knapp, (unknown)	82
20	Primary medical care for children in Victoria. 1982 ·PubMed ·Samuel C. Mok	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact